Stockholders’ Equity (Details) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
Mar. 30, 2026 |
Feb. 20, 2026 |
Dec. 12, 2025 |
Dec. 04, 2025 |
Oct. 31, 2025 |
Oct. 01, 2025 |
Sep. 30, 2025 |
Sep. 29, 2025 |
Aug. 31, 2025 |
Aug. 04, 2025 |
Jul. 29, 2025 |
Jul. 08, 2025 |
Jun. 06, 2025 |
May 22, 2025 |
May 19, 2025 |
May 16, 2025 |
May 06, 2025 |
Apr. 08, 2025 |
Jan. 18, 2021 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Jan. 01, 2026 |
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,666,667
|
|
|
|
| Common stock, share authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,666,667
|
|
6,666,667
|
|
6,666,667
|
|
| Preferred stock, share authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
5,000,000
|
|
| Purchase warrant shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,668
|
|
16,668
|
|
|
|
| Shares of warrant |
|
|
|
|
190,476
|
|
70,668
|
|
70,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8.9985
|
|
|
|
|
|
|
|
|
|
| Prior days of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
61 days
|
|
|
|
| Aggregate gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.50%
|
|
|
|
| Management fee equal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00%
|
|
|
|
| Purchase agreement period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60 days
|
|
|
|
| Aggregate gross proceeds ipo (in Dollars) |
|
|
|
|
|
$ 2,500,000
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
$ 25,000
|
|
|
|
|
$ 1,999,942
|
|
|
|
| Sale of common stock (in Dollars) |
|
|
|
|
|
|
|
|
|
|
$ 518,225
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock exercised |
|
|
|
|
|
|
61,112
|
|
61,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash proceeds for common stock (in Dollars) |
|
|
|
|
|
|
$ 634,922
|
|
$ 634,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,593,897
|
|
|
| Sale of stock |
|
|
|
|
|
|
|
190,476
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
$ 0.0001
|
$ 0.0001
|
| Offering price per share (in Dollars per share) |
$ 5.1
|
$ 4.4205
|
|
|
$ 16.4063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11.25
|
|
$ 11.25
|
|
|
|
| Warrants and outstanding term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|
| Percentage of gross proceeds |
|
|
|
|
|
|
|
1.00%
|
|
|
|
|
|
|
|
|
1.00%
|
|
|
|
|
|
|
|
|
| Cash fee and management fee (in Dollars) |
|
|
|
|
|
|
|
$ 187,500
|
|
|
|
|
|
|
|
|
$ 187,500
|
|
|
|
|
|
|
|
|
| Commitment fee (in Dollars) |
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of trading days |
|
5 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees (in Dollars) |
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 311,846
|
$ 299,592
|
$ 567,139
|
573,416
|
|
|
| Research and development expense (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 518,225
|
|
| Cash proceeds (in Dollars) |
$ 714,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,227,957
|
|
|
|
|
| Entire consideration (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 714,000
|
|
|
|
| Stock repurchase program authorized (in Dollars) |
|
$ 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares have been repurchased |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of lesser |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
| Provision percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
| Shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,128,610
|
|
1,128,610
|
|
887,886
|
|
| Number of stock granted |
|
|
|
3,667
|
|
|
|
|
|
3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Grant per share (in Dollars per share) |
|
|
|
$ 6.7725
|
|
|
|
|
|
$ 11.6355
|
|
|
|
$ 6.434
|
|
|
|
|
|
|
|
|
|
|
|
| Options value (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 167,566
|
|
|
|
|
|
|
|
|
|
|
|
| Risk-free interest rate |
|
|
|
3.68%
|
|
|
|
|
|
3.75%
|
|
|
|
3.96%
|
|
|
|
|
|
|
|
|
|
|
|
| Expected term |
|
|
|
5 years 6 months
|
|
|
|
|
|
5 years 6 months
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
| Expected volatility |
|
|
|
206.60%
|
|
|
|
|
|
206.76%
|
|
|
|
259.34%
|
|
|
|
|
|
|
|
|
|
|
|
| Options value (in Dollars) |
|
|
|
$ 24,487
|
|
|
|
|
|
$ 34,424
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 95,793
|
$ 17,445
|
|
|
| Unamortized stock-based compensation expense (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13,662
|
|
$ 13,662
|
|
$ 109,456
|
|
| Unamortized stock-based compensation expense recognized over a weighted average period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 months 6 days
|
|
|
|
| Percentage of exercise price of offering price per share |
|
|
|
|
11.25%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125.00%
|
|
|
|
| Purchase price per share (in Dollars per share) |
|
|
|
|
|
|
|
$ 13.125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceed from initial public offering (in Dollars) |
|
|
|
|
|
$ 2,131,339
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase warrant shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
|
|
|
|
| Aggregate gross proceeds ipo (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 365,940
|
|
|
|
| Stock exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
|
|
|
|
|
| May 2025 Prefunded Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
|
|
|
|
| May 2025 Series A-1 Common Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
9,556
|
|
9,556
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| May 2025 Series A-2 Common Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,230
|
|
|
|
|
|
|
|
|
|
| Warrant percentage not excess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
| Series A-2 warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9
|
|
|
|
|
|
|
|
|
|
| Stock exercised |
|
|
|
|
|
|
|
|
|
|
|
|
55,556
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series A-2 Common Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.9985
|
|
|
|
|
|
|
|
|
|
| May 2025 Common Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9
|
|
$ 9
|
|
|
|
| Percentage of share owned outstanding common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.99%
|
|
|
|
| Warrant percentage not excess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.99%
|
|
|
|
| May 2025 Prefunded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.0015
|
|
$ 0.0015
|
|
|
|
| May 2025 Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.25
|
|
$ 11.25
|
|
|
|
| Aggregate gross proceeds of warrants (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 117,320
|
|
|
|
| Pre-Funded Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of warrant |
|
56,555
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of common stock (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 365,940
|
|
|
|
| Stock exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
|
|
|
|
|
| May 2025 Series A-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock exercised |
|
|
|
|
|
|
|
|
|
|
|
|
55,556
|
|
|
|
|
|
|
|
|
|
|
|
|
| October 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11.25
|
|
$ 11.25
|
|
|
|
| Common Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consultant Fee (in Dollars) |
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
| Series A1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock exercised |
|
|
|
|
|
|
61,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
181,556
|
55,556
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0015
|
|
|
|
|
|
|
|
|
|
| Cash (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 61
|
|
|
|
|
|
|
|
|
|
|
| Cash proceeds for common stock (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 61
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock |
|
|
4,444
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
$ 10.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18
|
|
|
|
|
| Common stock for cash proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price per share (in Dollars per share) |
|
|
$ 225
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | May 2025 Series A-1 Common Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,230
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Series A-2 warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,230
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | May 2025 Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,668
|
|
16,668
|
|
|
|
| Common Stock [Member] | Pre-Funded Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | May 2025 Series A-2 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
55,556
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash proceeds for common stock (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
14,287
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of warrant |
|
|
18,689
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 Omnibus Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock reserved and avail for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,333
|
|
|
|
|
|
|
| May 2025 Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 290,000
|
|
|
|
| Aggregate gross proceeds ipo (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,634,002
|
|
|
|
| May 2025 Purchase Agreement [Member] | May 2025 Series A-1 Common Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222,230
|
|
|
|
|
|
|
|
|
|
| May 2025 Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
70,668
|
|
70,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MAVS Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
| Many Ads Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
140,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| May 2025 Public Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
181,556
|
|
|
|
|
|
|
|
|
|
| IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9
|
|
$ 9
|
|
|
|
| Sale of common stock (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,227,957
|
|
|
|
| IPO [Member] | Pre-Funded Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8.9985
|
|
$ 8.9985
|
|
|
|
| October 2025 Registered Direct Offering with Concurrent Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 65,211
|
|
|
|
| Aggregate gross proceeds ipo (in Dollars) |
|
|
|
|
$ 2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of each warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
1
|
|
|
|
| Warrants and outstanding term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,131,339
|
|
|
|
| Offering costs (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 303,450
|
|
303,450
|
|
|
|
| October 2025 Registered Direct Offering with Concurrent Private Placement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock |
|
|
|
|
|
|
|
190,476
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value (in Dollars per share) |
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering price per share (in Dollars per share) |
|
|
|
|
|
|
|
$ 13.125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Agent [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of gross proceeds |
|
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
|
| Percentage of exercise price of offering price per share |
|
|
|
|
125.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock Issued for Services [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 62,500
|
|
89,212
|
|
|
|
| Commitment Fee Share [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Professional fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
160,788
|
|
|
|
| 2020 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
26,665
|
|
|
|
|
|
|
|
|
|
|
|
| License [Member] | May 2025 Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 116,045
|
|
|
|
| Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public offering shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,667
|
|
|
|
|
|
|
|
|
|
|
| Wainwright & Co., LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00%
|
|
|
|
|
|
|
|
| Wainwright & Co., LLC [Member] | October 2025 Registered Direct Offering with Concurrent Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase warrant shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,287
|
|
14,287
|
|
|
|
| Legal fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
| Aggregate gross proceeds ipo (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,000
|
|
|
|
|
|
|
|
| Warrants and outstanding term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
5 years
|
|
|
|
| Percentage of gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
| Cash fee and management fee (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 187,500
|
|
|
|
|
|
|
|
| Percentage of warrants purchase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.50%
|
|
|
|
| Offering price per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 16.4063
|
|
|
|
| Other Expenses (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,000
|
|
|
|
| Clearing fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,950
|
|
|
|
| H.C. Wainwright & Co., [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal fees (in Dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 120,000
|
|
|
|
| October 2025 Registered Direct Offering with Concurrent Private Placement [Member] | Wainwright & Co., LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
125.00%
|
|
|
|
| May 2025 Investors [Member] | Series A1 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common warrants issued |
|
|
|
|
|
|
9,556
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
$ 150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,394
|
| Minimum [Member] | Board of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
| Minimum [Member] | Plan Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock reserved and avail for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,333
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in Dollars per share) |
|
|
$ 262.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137,727
|
| Maximum [Member] | Board of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31,333
|
|
|
|
|
|
|
| Maximum [Member] | Plan Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders’ Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock reserved and avail for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93,333
|
|
|
|
|
|
|